PANoptosis: a new insight into the mechanism of ischaemia–reperfusion injury

Abstract

Programmed cell death, which occurs via modes such as apoptosis, necroptosis, and pyroptosis, is an important mechanism for host defence against pathogens and inflammation-mediated immune responses. Recently, interactions between various types of cell death have gradually been discovered. PANoptosis is a newly discovered mode of programmed cell death that involves apoptosis, necroptosis, and pyroptosis and is closely related to many diseases. Ischaemia–reperfusion injury (IRI) is common in patients with blood circulation disorders such as those related to burns, traumatic shock, surgery, organ transplantation, and thrombus. However, the literature on the role of PANoptosis in IRI is limited. Herein, we systematically described the emergence of PANoptosis as a cell death mode, clinical evidence of its occurrence, the molecular mechanisms of PANoptosis, and its role in IRI. This study is expected to provide novel approaches for the prevention and treatment of tissue and organ IRI after severe burns.

Keywords

PANoptosis / PANoptosome / Apoptosis / Necroptosis / Pyroptosis / Ischaemia–reperfusion injury

References

[1] Bedoui S, Herold MJ, Strasser A. Emerging connectivity of programmed cell death pathways and its physiological implications. Nat Rev Mol Cell Biol. 2020; 21: 678-95. https://doi.org/10.1038/s41580-020-0270-8.

[2] Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cell Mol Immunol. 2021; 18: 1106-21. https://doi.org/10.1038/s41423-020-00630-3.

[3] Kuriakose T, Man SM, Malireddi RK, Karki R, Kesavardhana S, Place DE, et al. ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci Immunol. 2016; 1: aag2045. https://doi.org/10.1126/sciimmunol.aag2045.

[4] Tsuchiya K, Nakajima S, Hosojima S, Thi Nguyen D, Hattori T, Manh Le T, et al. Caspase-1 initiates apoptosis in the absence of gasdermin D. Nat Commun. 2019; 10: 2091. https://doi.org/10.1038/s41467-019-09753-2.

[5] Guo CH, Fu R, Zhou MJ, Wang S, Huang Y, Hu H, et al. Pathogenesis of lupus nephritis: RIP3 dependent necroptosis and NLRP3 inflammasome activation. J Autoimmun. 2019; 103: 102286. https://doi.org/10.1016/j.jaut.2019.05.014.

[6] Kesavardhana S, Kuriakose T, Guy CS, Samir P, Malireddi RKS, Mishra A, et al. ZBP1/DAI ubiquitination and sensing of influenza vRNPs activate programmed cell death. J Exp Med. 2017; 214: 2217-29. https://doi.org/10.1084/jem.20170550.

[7] Malireddi RKS, Kesavardhana S, Kanneganti TD. ZBP1 and TAK1: master regulators of NLRP3 inflammasome/pyroptosis, apoptosis, and necroptosis (PAN-optosis). Front Cell Infect Microbiol. 2019; 9: 406. https://doi.org/10.3389/fcimb.2019.00406.

[8] Shi C, Cao P, Wang Y, Zhang Q, Zhang D, Wang Y, et al. PANoptosis: a cell death characterized by pyroptosis, apoptosis, and necroptosis. J Inflamm Res. 2023; 16: 1523-32. https://doi.org/10.2147/JIR.S403819.

[9] Lee S, Karki R, Wang Y, Nguyen LN, Kalathur RC, Kanneganti TD. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defense. Nature. 2021; 597: 415-9. https://doi.org/10.1038/s41586-021-03875-8.

[10] Karki R, Sharma BR, Tuladhar S, Williams EP, Zalduondo L, Samir P, et al. Synergism of TNF-α and IFN-γ triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes. Cell. 2021; 184: 149-168.e17. https://doi.org/10.1016/j.cell.2020.11.025.

[11] Banoth B, Tuladhar S, Karki R, Sharma BR, Briard B, Kesavardhana S, et al. ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis). J Biol Chem. 2020; 295: 18276-83. https://doi.org/10.1074/jbc.RA120.015924.

[12] Karki R, Sharma BR, Lee E, Banoth B, Malireddi RKS, Samir P, et al. Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer. JCI Insight. 2020; 5:e136720. https://doi.org/10.1172/jci.insight.136720.

[13] Sun X, Yang Y, Meng X, Li J, Liu X, Liu H. PANoptosis: mechanisms, biology, and role in disease. Immunol Rev. 2024; 321: 246-62. https://doi.org/10.1111/imr.13279.

[14] Zhang M, Liu Q, Meng H, Duan H, Liu X, Wu J, et al. Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets. Signal Transduct Target Ther. 2024; 9: 12. https://doi.org/10.1038/s41392-023-01688-x.

[15] Capuzzimati M, Hough O, Liu M. Cell death and ischemia-reperfusion injury in lung transplantation. J Heart Lung Transplant. 2022; 41: 1003-13. https://doi.org/10.1016/j.healun.2022.05.013.

[16] Hayase N, Doi K, Hiruma T, Matsuura R, Hamasaki Y, Noiri E, et al. Recombinant thrombomodulin on neutrophil extracellular traps in murine intestinal ischemia-reperfusion. Anesthesiology. 2019; 131: 866-82. https://doi.org/10.1097/ALN.0000000000002898.

[17] Man SM, Karki R, Kanneganti TD. Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev. 2017; 277: 61-75. https://doi.org/10.1111/imr.12534.

[18] Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002; 10: 417-26. https://doi.org/10.1016/S1097-2765(02)00599-3.

[19] Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972; 26: 239-57. https://doi.org/10.1038/bjc.1972.33.

[20] Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell. 1997; 91: 479-89. https://doi.org/10.1016/S0092-8674(00)80434-1.

[21] Vanden Berghe T, Hassannia B, Vandenabeele P. An outline of necrosome triggers. Cell Mol Life Sci. 2016; 73: 2137-52. https://doi.org/10.1007/s00018-016-2189-y.

[22] Malireddi RKS, Gurung P, Kesavardhana S, Samir P, Burton A, Mummareddy H, et al. Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease. J Exp Med. 2020; 217. https://doi.org/10.1084/jem.20191644.

[23] Zheng M, Karki R, Vogel P, Kanneganti TD. Caspase-6 is a key regulator of innate immunity, inflammasome activation, and host defense. Cell. 2020; 181: 674-687.e13. https://doi.org/10.1016/j.cell.2020.03.040.

[24] Sundaram B, Pandian N, Mall R, Wang Y, Sarkar R, Kim HJ, et al. NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs. Cell. 2023; 186: 2783-2801.e20. https://doi.org/10.1016/j.cell.2023.05.005.

[25] Wang L, Zhu Y, Zhang L, Guo L, Wang X, Pan Z, et al. Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases. Cell Death Dis. 2023; 14: 851. https://doi.org/10.1038/s41419-023-06370-2.

[26] Sundaram B, Kanneganti TD. Advances in understanding activation and function of the NLRC4 inflammasome. Int J Mol Sci. 2021; 22: 1048. https://doi.org/10.3390/ijms22031048.

[27] Christgen S, Tweedell RE, Kanneganti TD. Programming inflammatory cell death for therapy. Pharmacol Ther. 2022; 232: 108010. https://doi.org/10.1016/j.pharmthera.2021.108010.

[28] Zheng M, Kanneganti TD. The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis). Immunol Rev. 2020; 297: 26-38. https://doi.org/10.1111/imr.12909.

[29] Sundaram B, Pandian N, Kim HJ, Abdelaal HM, Mall R, Indari O, et al. NLRC5 senses NAD+ depletion, forming a PANoptosome and driving PANoptosis and inflammation. Cell. 2024; 187: 4061-4077.e17. https://doi.org/10.1016/j.cell.2024.05.034.

[30] Sharma BR, Karki R, Kanneganti TD. Role of AIM2 inflammasome in inflammatory diseases, cancer and infection. Eur J Immunol. 2019; 49: 1998-2011. https://doi.org/10.1002/eji.201848070.

[31] Sridharan H, Ragan KB, Guo H, Gilley RP, Landsteiner VJ, Kaiser WJ, et al. Murine cytomegalovirus IE3-dependent transcription is required for DAI/ZBP1-mediated necroptosis. EMBO Rep. 2017; 18: 1429-41. https://doi.org/10.15252/embr.201743947.

[32] Kuriakose T, Kanneganti TD. ZBP1: innate sensor regulating cell death and inflammation. Trends Immunol. 2018; 39: 123-34. https://doi.org/10.1016/j.it.2017.11.002.

[33] Kesavardhana S, Malireddi RKS, Burton AR, Porter SN, Vogel P, Pruett-Miller SM, et al. The Zα2 domain of ZBP1 is a molecular switch regulating influenza-induced PANoptosis and perinatal lethality during development. J Biol Chem. 2020; 295: 8325-30. https://doi.org/10.1074/jbc.RA120.013752.

[34] Kesavardhana S, Malireddi RKS, Kanneganti TD. Caspases in cell death, inflammation, and pyroptosis. Annu Rev Immunol. 2020; 38: 567-95. https://doi.org/10.1146/annurev-immunol-073119-095439.

[35] Van Opdenbosch N, Lamkanfi M. Caspases in cell death, inflammation, and disease. Immunity. 2019; 50: 1352-64. https://doi.org/10.1016/j.immuni.2019.05.020.

[36] Jiang M, Qi L, Li L, Wu Y, Song D, Li Y. Caspase-8: a key protein of cross-talk signal way in "PANoptosis" in cancer. Int J Cancer. 2021; 149: 1408-20. https://doi.org/10.1002/ijc.33698.

[37] Fritsch M, Günther SD, Schwarzer R, Albert MC, Schorn F, Werthenbach JP, et al. Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis. Nature. 2019; 575: 683-7. https://doi.org/10.1038/s41586-019-1770-6.

[38] Zhu L, Lama S, Tu L, Dusting GJ, Wang JH, Liu GS. TAK1 signaling is a potential therapeutic target for pathological angiogenesis. Angiogenesis. 2021; 24: 453-70. https://doi.org/10.1007/s10456-021-09787-5.

[39] Geng J, Ito Y, Shi L, Amin P, Chu J, Ouchida AT, et al. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. Nat Commun. 2017; 8: 359. https://doi.org/10.1038/s41467-017-00406-w.

[40] Malireddi RKS, Bynigeri RR, Mall R, Nadendla EK, Connelly JP, Pruett-Miller SM, et al. Whole-genome CRISPR screen identifies RAVER1 as a key regulator of RIPK1-mediated inflammatory cell death. PANoptosis iScience. 2023; 26: 106938. https://doi.org/10.1016/j.isci.2023.106938.

[41] Malireddi RKS, Tweedell RE, Kanneganti TD. PANoptosis components, regulation, and implications. Aging (Albany NY). 2020; 12: 11163-4. https://doi.org/10.18632/aging.103528.

[42] Pan H, Pan J, Li P, Gao J. Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer. Clin Immunol. 2022; 238: 109019. https://doi.org/10.1016/j.clim.2022.109019.

[43] Ouyang G, Li Q, Wei Y, Dai W, Deng H, Liu Y, et al. Identification of PANoptosis-related subtypes, construction of a prognosis signature, and tumor microenvironment landscape of hepatocellular carcinoma using bioinformatic analysis and experimental verification. Front Immunol. 2024; 15: 1323199. https://doi.org/10.3389/fimmu.2024.1323199.

[44] Yi X, Li J, Zheng X, Xu H, Liao D, Zhang T, et al. Construction of PANoptosis signature: novel target discovery for prostate cancer immunotherapy. Mol Ther Nucleic Acids. 2023; 33: 376-90. https://doi.org/10.1016/j.omtn.2023.07.010.

[45] Wang JM, Yang J, Xia WY, Wang YM, Zhu YB, Huang Q, et al. Comprehensive analysis of PANoptosis-related gene signature of ulcerative colitis. Int J Mol Sci. 2023; 25: 348. https://doi.org/10.3390/ijms25010348.

[46] Yang Q, Song W, Reheman H, Wang D, Qu J, Li Y. PANoptosis, an indicator of COVID-19 severity and outcomes. Brief Bioinform. 2024; 25: bbae124. https://doi.org/10.1093/bib/bbae124.

[47] Li K, Wei M, Zhang D, Zhai S, Liu H. PANoptosis in vascular smooth muscle cells regulated by TNF-α/IL-1β can be a new target for alleviating the progression of abdominal aortic aneurysm. Physiol Genomics. 2024; 56: 158-66. https://doi.org/10.1152/physiolgenomics.00053.2023.

[48] Shi R, Liang R, Wang F, Wang L, Zidai W, Zhang J, et al. Identification and experimental validation of PYCARD as a crucial PANoptosis-related gene for immune response and inflammation in COPD. Apoptosis. 2024; 29: 2091-107. https://doi.org/10.1007/s10495-024-01961-6.

[49] Lan Z, Yang Y, Sun R, Lin X, Yan J, Chen X, et al. Characterization of PANoptosis-related genes with immunoregulatory features in osteoarthritis. Int Immunopharmacol. 2024; 140: 112889. https://doi.org/10.1016/j.intimp.2024.112889.

[50] Eltzschig HK, Eckle T. Ischemia and reperfusion-from mechanism to translation. Nat Med. 2011; 17: 1391-401. https://doi.org/10.1038/nm.2507.

[51] Zhang Q, Jia M, Wang Y, Wang Q, Wu J. Cell death mechanisms in cerebral ischemia-reperfusion injury. Neurochem Res. 2022; 47: 3525-42. https://doi.org/10.1007/s11064-022-03697-8.

[52] Kapanova G, Tashenova G, Akhenbekova A, Tokpınar A, Yılmaz S. Cerebral ischemia reperfusion injury: from public health perspectives to mechanisms. Folia Neuropathol. 2022; 60: 384-9. https://doi.org/10.5114/fn.2022.120101.

[53] Zhang F, Ran Y, Tahir M, Li Z, Wang J, Chen X. Regulation of N6-methyladenosine (m6A) RNA methylation in microglia-mediated inflammation and ischemic stroke. Front Cell Neurosci. 2022; 16: 955222. https://doi.org/10.3389/fncel.2022.955222.

[54] Ren Q, Hu Z, Jiang Y, Tan X, Botchway BOA, Amin N, et al. SIRT1 protects against apoptosis by promoting autophagy in the oxygen glucose deprivation/reperfusion-induced injury. Front Neurol. 2019; 10: 1289. https://doi.org/10.3389/fneur.2019.01289.

[55] Song M, Xia W, Tao Z, Zhu B, Zhang W, Liu C, et al. Self-assembled polymeric nanocarrier-mediated co-delivery of metformin and doxorubicin for melanoma therapy. Drug Deliv. 2021; 28: 594-606. https://doi.org/10.1080/10717544.2021.1898703.

[56] Poh L, Kang SW, Baik SH, Ng GYQ, She DT, Balaganapathy P, et al. Evidence that NLRC4 inflammasome mediates apoptotic and pyroptotic microglial death following ischemic stroke. Brain Behav Immun. 2019; 75: 34-47. https://doi.org/10.1016/j.bbi.2018.09.001.

[57] Wu X, Lin L, Qin JJ, Wang L, Wang H, Zou Y, et al. CARD3 promotes cerebral ischemia-reperfusion injury via activation of TAK1. J Am Heart Assoc. 2020; 9:e014920. https://doi.org/10.1161/JAHA.119.014920.

[58] Naito MG, Xu D, Amin P, Lee J, Wang H, Li W, et al. Sequential activation of necroptosis and apoptosis cooperates to mediate vascular and neural pathology in stroke. Proc Natl Acad Sci USA. 2020; 117: 4959-70. https://doi.org/10.1073/pnas.1916427117.

[59] Qiu Y, Fan Y, Huang G, Liu J. N6-methyladenosine demethylase ALKBH5 homologous protein protects against cerebral I/R injury though suppressing SNHG3-mediated neural PANoptosis: involvement of m6A-related macromolecules in the diseases of nervous system. Int J Biol Macromol. 2024; 274: 133815. https://doi.org/10.1016/j.ijbiomac.2024.133815.

[60] Etz CD, Weigang E, Hartert M, Lonn L, Mestres CA, Di Bartolomeo R, et al. Contemporary spinal cord protection during thoracic and thoracoabdominal aortic surgery and endovascular aortic repair: a position paper of the vascular domain of the European Association for Cardio-thoracic Surgery. Eur J Cardiothorac Surg. 2015; 47: 943-57. https://doi.org/10.1093/ejcts/ezv142.

[61] Sueda T, Takahashi S. Spinal cord injury as a complication of thoracic endovascular aneurysm repair. Surg Today. 2018; 48: 473-7. https://doi.org/10.1007/s00595-017-1588-5.

[62] Xie L, Wu H, Shi W, Zhang J, Huang X, Yu T. Melatonin exerts an anti-Panoptoic role in spinal cord ischemia-reperfusion injured rats. Adv Biol (Weinh). 2024; 8:e2300424. https://doi.org/10.1002/adbi.202300424.

[63] Xie L, Wu H, He Q, Shi W, Zhang J, Xiao X, et al. A slow-releasing donor of hydrogen sulfide inhibits neuronal cell death via anti-PANoptosis in rats with spinal cord ischemia-reperfusion injury. Cell Commun Signal. 2024; 22: 33. https://doi.org/10.1186/s12964-023-01457-x.

[64] Yao L, He F, Zhao Q, Li D, Fu S, Zhang M, et al. Spatial multiplexed protein profiling of cardiac ischemia-reperfusion injury. Circ Res. 2023; 133: 86-103. https://doi.org/10.1161/CIRCRESAHA.123.322620.

[65] Heusch G.Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol. 2020; 17: 773-89. https://doi.org/10.1038/s41569-020-0403-y.

[66] Zhou J, Xia W, Chen J, Han K, Jiang Y, Zhang A, et al. Propofol and salvianolic acid A synergistically attenuated cardiac ischemia-reperfusion injury in diabetic mice via modulating the CD36/AMPK pathway. Burns Trauma. 2024; 12: tkad055. https://doi.org/10.1093/burnst/tkad055.

[67] Cui B, Qi Z, Liu W, Zhang G, Lin D. ZBP1-mediated PANoptosis: a possible novel mechanism underlying the therapeutic effects of penehyclidine hydrochloride on myocardial ischemia-reperfusion injury. Int Immunopharmacol. 2024; 137: 112373. https://doi.org/10.1016/j.intimp.2024.112373.

[68] Li PB, Bai JQ, Jiang WX, Li HH, Li CM. The mechanosensitive Piezo1 channel exacerbates myocardial ischaemia/reperfusion injury by activating caspase-8-mediated PANoptosis. Int Immunopharmacol. 2024; 139: 112664. https://doi.org/10.1016/j.intimp.2024.112664.

[69] Minhas G, Sharma J, Khan N. Cellular stress response and immune signaling in retinal ischemia-reperfusion injury. Front Immunol. 2016; 7: 444. https://doi.org/10.3389/fimmu.2016.00444.

[70] Yan WT, Zhao WJ, Hu XM, Ban XX, Ning WY, Wan H, et al. PANoptosis-like cell death in ischemia/reperfusion injury of retinal neurons. Neural Regen Res. 2023; 18: 357-63.

[71] Shiva N, Sharma N, Kulkarni YA, Mulay SR, Gaikwad AB. Renal ischemia/reperfusion injury: an insight on in vitro and in vivo models. Life Sci. 2020; 256: 117860. https://doi.org/10.1016/j.lfs.2020.117860.

[72] Lasorsa F, Rutigliano M, Milella M, d’Amati A, Crocetto F, Pandolfo SD, et al. Ischemia-reperfusion injury in kidney transplantation: mechanisms and potential therapeutic targets. Int J Mol Sci. 2024; 25: 4332. https://doi.org/10.3390/ijms25084332.

[73] Uysal E, Dokur M, Kucukdurmaz F, Altınay S, Polat S, Batcıoglu K, et al. Targeting the PANoptosome with 3,4-methylenedioxy-β-nitrostyrene, reduces PANoptosis and protects the kidney against renal ischemia-reperfusion injury. J Investig Surg. 2022; 35: 1824- 35. https://doi.org/10.1080/08941939.2022.2128117.